Bruce Caswell Acquires 3,175 Shares of Maximus (NYSE:MMS) Stock

Maximus, Inc. (NYSE:MMS) CEO Bruce Caswell acquired 3,175 shares of the firm’s stock in a transaction that occurred on Tuesday, February 10th. The stock was acquired at an average price of $78.45 per share, for a total transaction of $249,078.75. Following the completion of the acquisition, the chief executive officer directly owned 328,013 shares of the company’s stock, valued at $25,732,619.85. The trade was a 0.98% increase in their position. The purchase was disclosed in a filing with the SEC, which is available through the SEC website.

Maximus Price Performance

MMS stock opened at $73.65 on Friday. Maximus, Inc. has a 52-week low of $63.77 and a 52-week high of $100.00. The company has a quick ratio of 2.34, a current ratio of 2.34 and a debt-to-equity ratio of 0.88. The stock has a market cap of $4.02 billion, a price-to-earnings ratio of 11.21 and a beta of 0.57. The business has a fifty day moving average of $89.29 and a two-hundred day moving average of $86.46.

Maximus (NYSE:MMS) last released its quarterly earnings results on Thursday, February 5th. The health services provider reported $1.85 earnings per share for the quarter, topping analysts’ consensus estimates of $1.84 by $0.01. The business had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.37 billion. Maximus had a return on equity of 25.30% and a net margin of 6.92%.The company’s revenue was down 4.1% compared to the same quarter last year. During the same period in the prior year, the business posted $1.61 EPS. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. As a group, research analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 2nd. Investors of record on Friday, February 13th will be given a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date of this dividend is Friday, February 13th. This is an increase from Maximus’s previous quarterly dividend of $0.30. Maximus’s dividend payout ratio is 18.26%.

Hedge Funds Weigh In On Maximus

Several institutional investors have recently modified their holdings of MMS. Richardson Financial Services Inc. raised its stake in shares of Maximus by 29.6% in the fourth quarter. Richardson Financial Services Inc. now owns 451 shares of the health services provider’s stock valued at $39,000 after acquiring an additional 103 shares in the last quarter. Farther Finance Advisors LLC increased its holdings in Maximus by 69.0% during the 4th quarter. Farther Finance Advisors LLC now owns 284 shares of the health services provider’s stock worth $25,000 after purchasing an additional 116 shares during the period. Arizona State Retirement System raised its position in Maximus by 0.9% in the 3rd quarter. Arizona State Retirement System now owns 16,674 shares of the health services provider’s stock valued at $1,524,000 after purchasing an additional 156 shares in the last quarter. Parkside Financial Bank & Trust raised its position in Maximus by 21.7% in the 2nd quarter. Parkside Financial Bank & Trust now owns 879 shares of the health services provider’s stock valued at $62,000 after purchasing an additional 157 shares in the last quarter. Finally, GAMMA Investing LLC boosted its stake in shares of Maximus by 13.9% in the 3rd quarter. GAMMA Investing LLC now owns 1,337 shares of the health services provider’s stock valued at $122,000 after buying an additional 163 shares during the period. Institutional investors and hedge funds own 97.21% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have commented on MMS. Wall Street Zen cut Maximus from a “buy” rating to a “hold” rating in a research note on Saturday, February 7th. Weiss Ratings reiterated a “buy (b-)” rating on shares of Maximus in a report on Monday, December 29th. Finally, Zacks Research raised Maximus from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, December 30th. One equities research analyst has rated the stock with a Strong Buy rating and one has issued a Buy rating to the company’s stock. According to data from MarketBeat.com, Maximus currently has a consensus rating of “Strong Buy”.

About Maximus

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.